Crossover Comparative Bioavailability Study of Trazodone Contramid OAD 300 mg Extended-Release Caplets and Desyrel 100 mg Immediate-Release Tablets in Healthy Adult Volunteers Under Fasting Conditions.
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2012
At a glance
- Drugs Trazodone (Primary)
- Indications Depression
- Focus Pharmacokinetics
- Sponsors Altus Formulation Inc
- 01 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 13 Feb 2009 New trial record